YIA
EVFM

YHB Investment Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

YHB Investment Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-800
Closed -$9K – 319
2021
Q3 		$9K Buy
+800
New +$10.1K ﹤0.01% 303

Other funds holding EVFM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

YHB Investment Advisors's EVFM Position: Q4 2021 in Review

YHB Investment Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2021, closing a stake of 800 shares — an estimated $9K sold.

YHB Investment Advisors first reported a position in EVFM in Q3 2021 and held it in 1 quarter. The position peaked at $9K in Q3 2021. 62 funds tracked by Wall St. Rank hold EVFM as of Q4 2021.

  • YHB Investment Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • YHB Investment Advisors sold 800 Evofem Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $9K.
  • YHB Investment Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • YHB Investment Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $9K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2021.

Based on YHB Investment Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.